Open AccessCOVID-19 and rhino-orbital mucormycosis – a case report
Author(s) -
Dilbag Singh,
Harveen Kaur,
Kajal Nc
Publication year - 2021
Publication title -
journal of pulmonology and respiratory research
Language(s) - English
Resource type - Journals
ISSN - 2639-9954
DOI - 10.29328/journal.jprr.1001032
Subject(s) - mucormycosis , medicine , immunosuppression , nose , dermatology , diabetes mellitus , disease , respiratory tract , intensive care medicine , surgery , pathology , respiratory system , endocrinology
There is a constant rise in cases of rhino-orbital mucormycosis in people with Coronavirus disease 2019 (COVID-19). Generally, Mucormycosis develops in immunosuppression or debilitating diseases. In cases having head and neck involvement, the mold enters the respiratory tract with further involvement of nose and sinuses and there is consecutive progression into orbital and intracranial structures. Diabetes Mellitus (DM) is an independent risk factor for both severe COVID-19 and mucormycosis. The clinical examination and direct smears are helpful for early diagnosis of the disease and timely intervention. For the better prevention and management of such opportunistic infections in COVID-19 patients, it is prudent to establish prophylactic treatment protocols along with rational use of corticosteroids. We here report a case of Rhino-orbital Mucormycosis infection caused by Rhizopus oryzae in a COVID-19 patient with Diabetes Mellitus.